Schedule 13G ownership disclosure
DIPEXIUM PHARMACEUTICALS INC
Security class unavailable · CUSIP: 25456J104
Event date: 2014-11-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.5500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-14-006832
- Form type
- SC 13G
- Filer
- PLx Pharma Inc.
- CIK
- CIK 1497504
- Filed
- Nov 28, 2014
- Reporting period
- Nov 18, 2014
- Description
- Schedule 13G beneficial ownership